Format

Send to

Choose Destination
Eur J Cancer. 2018 Mar;92:119-120. doi: 10.1016/j.ejca.2017.12.004. Epub 2018 Jan 9.

Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab.

Author information

1
Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France.
2
Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France. Electronic address: william.raoul@univ-tours.fr.
3
Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France; CHRU de Tours, Department of Hepato-Gastroenterology and Digestive Oncology, Tours, France.
4
Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France; CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France.
PMID:
29329696
DOI:
10.1016/j.ejca.2017.12.004
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science Icon for HAL archives ouvertes
Loading ...
Support Center